Aptamers Market (2022 - 2032)
Aptamers Market Analysis By Type (Nucleic Acid Aptamers, Peptide Aptamers), By Technology (SELEX, X-aptamers, MARAS Technique), By Application (Diagnostics, Therapeutics, Research & Development), By End User - Global Market Insights 2022 to 2030
Core Findings
FREE CustomizationAptamers Market Outlook (2022 to 2030)
The global aptamers market has reached a valuation of US$ 2.4 billion in 2021. Progressing at a phenomenal CAGR of 21.6% over the next eight years, worldwide demand for aptamers is anticipated to rake in revenue worth US$ 11.5 billion by 2030.
Nucleic acid aptamers account for 77% of the global market share and are expected to maintain this dominant stance across the forecast period owing to increasing research on the use of nucleic acid aptamers in the treatment of several disorders.
| Report Attributes | Details |
|---|---|
| Aptamers Market Size (2022) | US$ 2.4 Billion |
| Projected Market Value (2030F) | US$ 11.5 Billion |
| Global Market Growth Rate (2022 to 2030) | 21.6% CAGR |
| North America Market Share (2022) | 45% |
| Nucleic Acid Aptamers Market Share (2022) | 77% |
| SELEX Technology Market Share (2022) | 75% |
| Key Companies Profiled | Aptamer Sciences Inc.; Somalogic Inc.; Base Pair Biotechnologies Inc.; Ophthotech Corporation; Am Biotechnologies; Aptamer Solutions Ltd.; Aptus Biotech S.L.; Neoventures Biotechnology Inc.; Aptagen LLC; Trilink Biotechnologies Inc.; Vivonics Inc.; Noxxon Pharma |
Sales Analysis of Aptamers (2017 to 2021) in Comparison to Market Estimations (2022 to 2030)
Oligonucleotide aptamers can quickly bind target proteins with high specificity and are inexpensive in comparison to antibodies, which is expected to propel their demand over the coming years. The scope of application for aptamers has been widening in recent years and this trend is expected to follow through across the forecast period as well owing to increasing investments in the R&D of aptamers and aptamer technologies.
High prevalence of chronic diseases has increased the demand for novel diagnostic procedures and this has benefitted the aptamers market potential as aptamers are being used to create new diagnostic tests. The use of aptamers was briefly researched while developing rapid test kits for COVID-19 in 2020 and this has boosted the market potential for the years to come.
Rising awareness of the use of aptamers, increasing investments in aptamer R&D, low costs of aptamers, increasing approvals for aptamer therapeutics, and continual development of novel aptamer technologies are other factors that are expected to positively impact aptamers market growth potential through 2030.
However, lack of standardization, short half-life, low awareness in developing regions, and ethical concerns regarding animal-derived aptamers are some prospects that could impede demand for aptamers over the next eight years.
The market for aptamers is projected to exhibit evolution at an astronomical CAGR of 21.6% from 2022 to 2030.
This revised analysis by Fact.MR, a market research and competitive intelligence provider, details a comprehensive account of all the opportunities in the aptamers market, along with the drivers, restraints, and challenges, to gain a complete understanding of the current and forecasted industry scenario.
Why is Adoption of Aptamers Low?
“Lack of Standardization & Low Awareness in Developing Regions”
There’s a lack of universal regulatory guidelines that dictate the quality and safety of aptamers unlike other drugs and diagnostic tools. This factor is expected to slow down the demand for aptamers in developed regions such as North America and Europe. Stringent rules for approval in these regions are also predicted to hamper the overall market potential across the forecast period.
Lack of awareness about these molecules in developing and underdeveloped regions such as Asia Pacific, Middle East, and Africa is also anticipated to slow down sales of aptamers over the next eight years.
“Absence of Adequate Knowledge & Short Half-life”
Aptamers are relatively new and unexplored as compared to other molecules and there are still many characteristics of aptamers that are unknown to us, which hinders the adoption of aptamers. The low molecular weight of aptamers leads to rapid degradation of biological media and to avoid this there is a need for proper synthesis to keep its unwanted characteristics in check. These molecules have a very short half-life ranging from minutes to hours, which obstructs their practical application scope and hampers adoption across the world.
All of the aforementioned factors along with a lack of expertise to handle aptamers are expected to impede market potential throughout the forecast period.
What Can New Market Entrants Do to Make a Mark in This Industry?
“Product Innovation Should Be Prime Focus of New Aptamer Companies”
Aptamers are still relatively new to humans and there is a sea of unexplored potential in the aptamers marketplace owing to the nascent nature of this technology. New market players are expected to have a wide array of opportunities to create substantial space for themselves in this marketplace and they are expected to enhance their research scope to fast-track product innovation.
- In 2021, Xsensio, a Swiss digital health start-up collaborated with scientists at the Swiss Federal Institute of Technology Lausanne (EPFL) to create a new graphene-based sensing system that detects stress hormone called cortisol in human sweat. The system uses a patch that contains a graphene-based electrode and transistor. The graphene is functionalized through aptamers with a negative charge that captures cortisol when it comes in contact to measure the concentration in the user’s sweat.
- In December 2020, Basking Biosciences Inc., a privately-held biopharmaceutical organization announced the initial closing of a US$ 5.4 million seed series financing. The funding was used for the development of a next-generation treatment of acute ischemic stroke (AIS) which involved the use of DTRI-031, an RNA aptamer that inhibits von Willebrand Factor (vWF).
New companies are also focusing on acquiring new financing to expand their research and business scope across the world.
- In September 2022, Nutromics, an Australian medical technology start-up, raised US$ 14 million in funding. The funding will be used to expand the company’s R&D activities and clinical studies across Australia and the United States. The company is known for the development of its aptamer sensor which enables continuous monitoring with high accuracy.
What’s Stimulating Aptamers Market Growth across Geographies?
“Increasing Investments in R&D - Common Driver for All Regional Markets”
The market for aptamers in North America currently accounts for a dominant market share of 45% and is expected to maintain this stance across the forecast period owing to high investments in healthcare research and the presence of key market players in this region. Increasing establishment of research facilities and high incidence of chronic diseases are other trends in aptamers marketplace that could drive growth in this region.
The growth of the aptamers market in Europe is anticipated to be dependent on factors such as increasing approvals for advanced technologies and rising demand for aptamer therapies. The future of the aptamers market in this region is expected to be dependent on advancements in aptamer technologies by key market players.
The Asia Pacific aptamers market is projected to provide highly rewarding opportunities for established as well as new market players alike owing to loose regulatory mandates and efforts of key market players to explore the untapped potential in this region. Increasing investments in healthcare infrastructure development and supportive government initiatives are also expected to boost aptamers market potential over the next eight years.
Key developments in the aptamers industry in economies such as China, Japan, and India are expected to lead the overall growth in the Asia Pacific region through 2030.
Country-wise Insights
What’s Attracting Suppliers of Aptamers to the U.S.?
“High Spending on Research and Presence of Modern Healthcare Facilities”
The United States is known across the world for its matured healthcare infrastructure and developed healthcare research facilities that are equipped with state-of-art technologies and equipment. This makes it a highly attractive market for all healthcare research purposes and hence, provides a plethora of opportunities for aptamer companies.
Supportive government funding to advance research, the presence of key biotechnology and biopharmaceutical companies, rapid adoption of novel technologies, and high healthcare expenditure are other factors that could potentially uplift aptamers market growth through 2030.
Category-wise Insights
Why is SELEX the Gold Standard Technology in Aptamers?
“Continuous Advancements in SELEX Technique Makes it Crucial for Market Evolution”
The global aptamers market, based on technology, is segmented into SELEX, X-aptamers, MARAS technique, and others.
Systemic Evolution of Ligands by Exponential Enrichment (SELEX) technique has been used for a long time for the selection of aptamers, but the conventional technique involved time-consuming steps that would delay the whole selection process. To counter this, companies in the aptamers marketplace have been continuously investing in advancements of SELEX technologies, which is what drives the popularity of this technology in the industry landscape. The SELEX technology segment accounts for around 75% of the global market share at present.
Higher efficiency, simplified enzymatic steps, and faster selection are expected to be key prospects in driving the popularity of Magnetic-assisted Rapid Aptamer Selection (MARAS) techniques through 2030.
Competitive Landscape
Top aptamer companies are anticipated to focus on research and development of new aptamer-based products to strengthen their market stance.
- In November 2021, Achiko, a healthcare technology company announced the development of a new DNA aptamer-based dengue fever diagnostic test.
Key Segments in Aptamers Industry Research
-
By Type:
- Nucleic Acid Aptamers
- DNA Aptamers
- RNA Aptamers
- XNA Aptamers
- Peptide Aptamers
- Nucleic Acid Aptamers
-
By Application:
- Diagnostics
- Therapeutics
- Research & Development
- Others
-
By Technology:
- SELEX
- X-aptamers
- MARAS Technique
- Others
-
By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Government Research Institutes
- CROs
- Others
-
By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030)
- 6. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030), by Application
- 6.1. Diagnostics
- 6.2. Therapeutics
- 6.3. Research & Development
- 6.4. Others
- 7. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030), by Type
- 7.1. Nucleic Acid Aptamers
- 7.2. Peptide Aptamers
- 8. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030), by Technology
- 8.1. SELEX
- 8.2. X-aptamers
- 8.3. MARAS Technique
- 8.4. Others
- 9. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030), by End User
- 9.1. Pharmaceutical & Biotechnology Companies
- 9.2. Academic & Government Research Institutes
- 9.3. CROs
- 9.4. Others
- 10. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2030), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Aptamer Sciences Inc.
- 20.2. Somalogic Inc.
- 20.3. Base Pair Biotechnologies Inc.
- 20.4. Ophthotech Corporation
- 20.5. Am Biotechnologies
- 20.6. Aptamer Solutions Ltd.
- 20.7. Aptus Biotech S.L.
- 20.8. Neoventures Biotechnology Inc.
- 20.9. Aptagen LLC
- 20.10. Trilink Biotechnologies Inc.
- 20.11. Vivonics Inc.
- 20.12. Noxxon Pharma
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
List Of Table
Table 01: Global Market Volume (Units), by Application, 2017 to 2030
Table 02: Global Market Value (US$ Mn), by Application, 2017 to 2030
Table 03: Global Market Volume (Units), by Type, 2017 to 2030
Table 04: Global Market Value (US$ Mn), by Type, 2017 to 2030
Table 05: Global Market Volume (Units), by Technology, 2017 to 2030
Table 06: Global Market Value (US$ Mn), by Technology, 2017 to 2030
Table 07: Global Market Volume (Units), by End User, 2017 to 2030
Table 08: Global Market Value (US$ Mn), by End User, 2017 to 2030
Table 09: Global Market Volume (Units), by Region, 2017 to 2030
Table 10: Global Market Value (US$ Mn), by Region, 2017 to 2030
Table 11: North America Market Volume (Units), by Application, 2017 to 2030
Table 12: North America Market Value (US$ Mn), by Application, 2017 to 2030
Table 13: North America Market Volume (Units), by Type, 2017 to 2030
Table 14: North America Market Value (US$ Mn), by Type, 2017 to 2030
Table 15: North America Market Volume (Units), by Technology, 2017 to 2030
Table 16: North America Market Value (US$ Mn), by Technology, 2017 to 2030
Table 17: North America Market Volume (Units), by End User, 2017 to 2030
Table 18: North America Market Value (US$ Mn), by End User, 2017 to 2030
Table 19: North America Market Volume (Units), by Country, 2017 to 2030
Table 20: North America Market Value (US$ Mn), by Country, 2017 to 2030
Table 21: Europe Market Volume (Units), by Application, 2017 to 2030
Table 22: Europe Market Value (US$ Mn), by Application, 2017 to 2030
Table 23: Europe Market Volume (Units), by Type, 2017 to 2030
Table 24: Europe Market Value (US$ Mn), by Type, 2017 to 2030
Table 25: Europe Market Volume (Units), by Technology, 2017 to 2030
Table 26: Europe Market Value (US$ Mn), by Technology, 2017 to 2030
Table 27: Europe Market Volume (Units), by End User, 2017 to 2030
Table 28: Europe Market Value (US$ Mn), by End User, 2017 to 2030
Table 29: Europe Market Volume (Units), by Country, 2017 to 2030
Table 30: Europe Market Value (US$ Mn), by Country, 2017 to 2030
Table 31: East Asia Market Volume (Units), by Application, 2017 to 2030
Table 32: East Asia Market Value (US$ Mn), by Application, 2017 to 2030
Table 33: East Asia Market Volume (Units), by Type, 2017 to 2030
Table 34: East Asia Market Value (US$ Mn), by Type, 2017 to 2030
Table 35: East Asia Market Volume (Units), by Technology, 2017 to 2030
Table 36: East Asia Market Value (US$ Mn), by Technology, 2017 to 2030
Table 37: East Asia Market Volume (Units), by End User, 2017 to 2030
Table 38: East Asia Market Value (US$ Mn), by End User, 2017 to 2030
Table 39: East Asia Market Volume (Units), by Country, 2017 to 2030
Table 40: East Asia Market Value (US$ Mn), by Country, 2017 to 2030
Table 41: South Asia Market Volume (Units), by Application, 2017 to 2030
Table 42: South Asia Market Value (US$ Mn), by Application, 2017 to 2030
Table 43: South Asia Market Volume (Units), by Type, 2017 to 2030
Table 44: South Asia Market Value (US$ Mn), by Type, 2017 to 2030
Table 45: South Asia Market Volume (Units), by Technology, 2017 to 2030
Table 46: South Asia Market Value (US$ Mn), by Technology, 2017 to 2030
Table 47: South Asia Market Volume (Units), by End User, 2017 to 2030
Table 48: South Asia Market Value (US$ Mn), by End User, 2017 to 2030
Table 49: South Asia Market Volume (Units), by Country, 2017 to 2030
Table 50: South Asia Market Value (US$ Mn), by Country, 2017 to 2030
Table 51: Latin America Market Volume (Units), by Application, 2017 to 2030
Table 52: Latin America Market Value (US$ Mn), by Application, 2017 to 2030
Table 53: Latin America Market Volume (Units), by Type, 2017 to 2030
Table 54: Latin America Market Value (US$ Mn), by Type, 2017 to 2030
Table 55: Latin America Market Volume (Units), by Technology, 2017 to 2030
Table 56: Latin America Market Value (US$ Mn), by Technology, 2017 to 2030
Table 57: Latin America Market Volume (Units), by End User, 2017 to 2030
Table 58: Latin America Market Value (US$ Mn), by End User, 2017 to 2030
Table 59: Latin America Market Volume (Units), by Country, 2017 to 2030
Table 60: Latin America Market Value (US$ Mn), by Country, 2017 to 2030
Table 61: Middle East and Africa Market Volume (Units), by Application, 2017 to 2030
Table 62: Middle East and Africa Market Value (US$ Mn), by Application, 2017 to 2030
Table 63: Middle East and Africa Market Volume (Units), by Type, 2017 to 2030
Table 64: Middle East and Africa Market Value (US$ Mn), by Type, 2017 to 2030
Table 65: Middle East and Africa Market Volume (Units), by Technology, 2017 to 2030
Table 66: Middle East and Africa Market Value (US$ Mn), by Technology, 2017 to 2030
Table 67: Middle East and Africa Market Volume (Units), by End User, 2017 to 2030
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2017 to 2030
Table 69: Middle East and Africa Market Volume (Units), by Country, 2017 to 2030
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2017 to 2030
Table 71: Oceania Market Volume (Units), by Application, 2017 to 2030
Table 72: Oceania Market Value (US$ Mn), by Application, 2017 to 2030
Table 73: Oceania Market Volume (Units), by Type, 2017 to 2030
Table 74: Oceania Market Value (US$ Mn), by Type, 2017 to 2030
Table 75: Oceania Market Volume (Units), by Technology, 2017 to 2030
Table 76: Oceania Market Value (US$ Mn), by Technology, 2017 to 2030
Table 77: Oceania Market Volume (Units), by End User, 2017 to 2030
Table 78: Oceania Market Value (US$ Mn), by End User, 2017 to 2030
Table 79: Oceania Market Volume (Units), by Country, 2017 to 2030
Table 80: Oceania Market Value (US$ Mn), by Country, 2017 to 2030
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2017 to 2030
Fig 02: Global Absolute $ Historical Market (2017 to 2021) and Absolute $ Opportunity (2022 to 2030), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2017 to 2021) and Absolute Volume Opportunity (2022 to 2030), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2030
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2022 to 2030
Fig 06: Global Market Share, By Application to 2022 to 2030
Fig 07: Global Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 08: Global Market Attractiveness Index, By Application to 2022 to 2030
Fig 09: Global Market Share, By Type to 2022 to 2030
Fig 10: Global Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 11: Global Market Attractiveness Index, By Type to 2022 to 2030
Fig 12: Global Market Share, By Technology to 2022 to 2030
Fig 13: Global Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 14: Global Market Attractiveness Index, By Technology to 2022 to 2030
Fig 15: Global Market Share, By End User to 2022 to 2030
Fig 16: Global Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 17: Global Market Attractiveness Index, By End User to 2022 to 2030
Fig 18: Global Market Share, by Region to 2022 to 2030
Fig 19: Global Market Y-o-Y Growth Projections, by Region to 2022 to 2030
Fig 20: Global Market Attractiveness Index, by Region to 2022 to 2030
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Application to 2022 to 2030
Fig 24: North America Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 25: North America Market Attractiveness Index, By Application to 2022 to 2030
Fig 26: North America Market Share, By Type to 2022 to 2030
Fig 27: North America Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 28: North America Market Attractiveness Index, By Type to 2022 to 2030
Fig 29: North America Market Share, By Technology to 2022 to 2030
Fig 30: North America Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 31: North America Market Attractiveness Index, By Technology to 2022 to 2030
Fig 32: North America Market Share, By End User to 2022 to 2030
Fig 33: North America Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 34: North America Market Attractiveness Index, By End User to 2022 to 2030
Fig 35: North America Market Share, By Country to 2022 to 2030
Fig 36: North America Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 37: North America Market Attractiveness Index, By Country to 2022 to 2030
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Application to 2022 to 2030
Fig 41: Europe Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 42: Europe Market Attractiveness Index, By Application to 2022 to 2030
Fig 43: Europe Market Share, By Type to 2022 to 2030
Fig 44: Europe Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 45: Europe Market Attractiveness Index, By Type to 2022 to 2030
Fig 46: Europe Market Share, By Technology to 2022 to 2030
Fig 47: Europe Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 48: Europe Market Attractiveness Index, By Technology to 2022 to 2030
Fig 49: Europe Market Share, By End User to 2022 to 2030
Fig 50: Europe Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 51: Europe Market Attractiveness Index, By End User to 2022 to 2030
Fig 52: Europe Market Share, By Country to 2022 to 2030
Fig 53: Europe Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 54: Europe Market Attractiveness Index, By Country to 2022 to 2030
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Application to 2022 to 2030
Fig 58: East Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 59: East Asia Market Attractiveness Index, By Application to 2022 to 2030
Fig 60: East Asia Market Share, By Type to 2022 to 2030
Fig 61: East Asia Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 62: East Asia Market Attractiveness Index, By Type to 2022 to 2030
Fig 63: East Asia Market Share, By Technology to 2022 to 2030
Fig 64: East Asia Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 65: East Asia Market Attractiveness Index, By Technology to 2022 to 2030
Fig 66: East Asia Market Share, By End User to 2022 to 2030
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 68: East Asia Market Attractiveness Index, By End User to 2022 to 2030
Fig 69: East Asia Market Share, By Country to 2022 to 2030
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 71: East Asia Market Attractiveness Index, By Country to 2022 to 2030
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Application to 2022 to 2030
Fig 75: South Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 76: South Asia Market Attractiveness Index, By Application to 2022 to 2030
Fig 77: South Asia Market Share, By Type to 2022 to 2030
Fig 78: South Asia Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 79: South Asia Market Attractiveness Index, By Type to 2022 to 2030
Fig 80: South Asia Market Share, By Technology to 2022 to 2030
Fig 81: South Asia Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 82: South Asia Market Attractiveness Index, By Technology to 2022 to 2030
Fig 83: South Asia Market Share, By End User to 2022 to 2030
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 85: South Asia Market Attractiveness Index, By End User to 2022 to 2030
Fig 86: South Asia Market Share, By Country to 2022 to 2030
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 88: South Asia Market Attractiveness Index, By Country to 2022 to 2030
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Application to 2022 to 2030
Fig 92: Latin America Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 93: Latin America Market Attractiveness Index, By Application to 2022 to 2030
Fig 94: Latin America Market Share, By Type to 2022 to 2030
Fig 95: Latin America Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 96: Latin America Market Attractiveness Index, By Type to 2022 to 2030
Fig 97: Latin America Market Share, By Technology to 2022 to 2030
Fig 98: Latin America Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 99: Latin America Market Attractiveness Index, By Technology to 2022 to 2030
Fig 100: Latin America Market Share, By End User to 2022 to 2030
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 102: Latin America Market Attractiveness Index, By End User to 2022 to 2030
Fig 103: Latin America Market Share, By Country to 2022 to 2030
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 105: Latin America Market Attractiveness Index, By Country to 2022 to 2030
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Application to 2022 to 2030
Fig 109: MEA Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 110: MEA Market Attractiveness Index, By Application to 2022 to 2030
Fig 111: MEA Market Share, By Type to 2022 to 2030
Fig 112: MEA Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 113: MEA Market Attractiveness Index, By Type to 2022 to 2030
Fig 114: MEA Market Share, By Technology to 2022 to 2030
Fig 115: MEA Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 116: MEA Market Attractiveness Index, By Technology to 2022 to 2030
Fig 117: MEA Market Share, By End User to 2022 to 2030
Fig 118: MEA Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 119: MEA Market Attractiveness Index, By End User to 2022 to 2030
Fig 120: MEA Market Share, By Country to 2022 to 2030
Fig 121: MEA Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 122: MEA Market Attractiveness Index, By Country to 2022 to 2030
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2030
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Application to 2022 to 2030
Fig 126: Oceania Market Y-o-Y Growth Projections, By Application to 2022 to 2030
Fig 127: Oceania Market Attractiveness Index, By Application to 2022 to 2030
Fig 128: Oceania Market Share, By Type to 2022 to 2030
Fig 129: Oceania Market Y-o-Y Growth Projections, By Type to 2022 to 2030
Fig 130: Oceania Market Attractiveness Index, By Type to 2022 to 2030
Fig 131: Oceania Market Share, By Technology to 2022 to 2030
Fig 132: Oceania Market Y-o-Y Growth Projections, By Technology to 2022 to 2030
Fig 133: Oceania Market Attractiveness Index, By Technology to 2022 to 2030
Fig 134: Oceania Market Share, By End User to 2022 to 2030
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User to 2022 to 2030
Fig 136: Oceania Market Attractiveness Index, By End User to 2022 to 2030
Fig 137: Oceania Market Share, By Country to 2022 to 2030
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country to 2022 to 2030
Fig 139: Oceania Market Attractiveness Index, By Country to 2022 to 2030
Fig 140: United States Market share by Application, 2021
Fig 141: United States Market share by Type, 2021
Fig 142: United States Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 143: United States Market Share by End User, 2021
Fig 144: Canada Market share by Application, 2021
Fig 145: Canada Market share by Type, 2021
Fig 146: Canada Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 147: Canada Market Share by End User, 2021
Fig 148: Germany Market share by Application, 2021
Fig 149: Germany Market share by Type, 2021
Fig 150: Germany Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 151: Germany Market Share by End User, 2021
Fig 152: United Kingdom Market share by Application, 2021
Fig 153: United Kingdom Market share by Type, 2021
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 155: United Kingdom Market Share by End User, 2021
Fig 156: France Market share by Application, 2021
Fig 157: France Market share by Type, 2021
Fig 158: France Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 159: France Market Share by End User, 2021
Fig 160: Russia Market share by Application, 2021
Fig 161: Russia Market share by Type, 2021
Fig 162: Russia Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 163: Russia Market Share by End User, 2021
Fig 164: Spain Market share by Application, 2021
Fig 165: Spain Market share by Type, 2021
Fig 166: Spain Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 167: Spain Market Share by End User, 2021
Fig 168: Italy Market share by Application, 2021
Fig 169: Italy Market share by Type, 2021
Fig 170: Italy Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 171: Italy Market Share by End User, 2021
Fig 172: China Market share by Application, 2021
Fig 173: China Market share by Type, 2021
Fig 174: China Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 175: China Market Share by End User, 2021
Fig 176: Japan Market share by Application, 2021
Fig 177: Japan Market share by Type, 2021
Fig 178: Japan Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 179: Japan Market Share by End User, 2021
Fig 180: South Korea Market share by Application, 2021
Fig 181: South Korea Market share by Type, 2021
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 183: South Korea Market Share by End User, 2021
Fig 184: India Market share by Application, 2021
Fig 185: India Market share by Type, 2021
Fig 186: India Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 187: India Market Share by End User, 2021
Fig 188: Singapore Market share by Application, 2021
Fig 189: Singapore Market share by Type, 2021
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 191: Singapore Market Share by End User, 2021
Fig 192: Indonesia Market share by Application, 2021
Fig 193: Indonesia Market share by Type, 2021
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 195: Indonesia Market Share by End User, 2021
Fig 196: Thailand Market share by Application, 2021
Fig 197: Thailand Market share by Type, 2021
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 199: Thailand Market Share by End User, 2021
Fig 200: Brazil Market share by Application, 2021
Fig 201: Brazil Market share by Type, 2021
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 203: Brazil Market Share by End User, 2021
Fig 204: Mexico Market share by Application, 2021
Fig 205: Mexico Market share by Type, 2021
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 207: Mexico Market Share by End User, 2021
Fig 208: Turkey Market share by Application, 2021
Fig 209: Turkey Market share by Type, 2021
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 211: Turkey Market Share by End User, 2021
Fig 212: GCC Countries Market share by Application, 2021
Fig 213: GCC Countries Market share by Type, 2021
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 215: GCC Countries Market Share by End User, 2021
Fig 216: South Africa Market share by Application, 2021
Fig 217: South Africa Market share by Type, 2021
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 219: South Africa Market Share by End User, 2021
Fig 220: Australia Market share by Application, 2021
Fig 221: Australia Market share by Type, 2021
Fig 222: Australia Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 223: Australia Market Share by End User, 2021
Fig 224: New Zealand Market share by Application, 2021
Fig 225: New Zealand Market share by Type, 2021
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2022 to 2030
Fig 227: New Zealand Market Share by End User, 2021
- FAQs -
How big is the global aptamers market?
The global aptamers market is currently valued at US$ 2.4 billion.
What is the estimated revenue for the aptamers market for 2030?
The global aptamers market is expected to reach US$ 11.5 billion by 2030-end.
At what pace is the aptamers market expected to evolve?
Aptamers market evolution is projected at an astronomical CAGR of 21.6% through 2030.
Which is the leading technology in the aptamers market?
The SELEX technology accounts for a dominant market share of 75% in 2022.
What are the key factors driving the sales of aptamers?
Increasing spending on R&D and continuous technological advancements are prime factors positively influencing aptamers market growth.
Which aptamer type accounts for the largest market share?
Based on type, nucleic acid aptamers account for 77% market share in 2022.
Which factors may limit the demand for aptamers?
Lack of standardized regulatory structure, ethical concerns regarding the use of animal-derived aptamers, and low awareness in certain regions are factors that can limit market growth.
Who are the key players operating in the aptamers market?
Prominent suppliers of aptamers are Aptamer Sciences Inc., Somalogic Inc., Base Pair Biotechnologies Inc., Ophthotech Corporation, Am Biotechnologies, Aptamer Solutions Ltd., Aptus Biotech S.L., and Neoventures.
Related Reports
Aptamers Market